We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.
- Authors
Kiortsis, D N; Mavridis, A K; Vasakos, S; Nikas, S N; Drosos, A A
- Abstract
Tumour necrosis factor alpha (TNFalpha) may be an important mediator of insulin resistance. Infliximab is a chimeric monoclonal, high affinity antibody against the soluble and transmembrane TNFalpha, which can reduce markedly the biological activity of circulating and tissue TNFalpha and is used to treat various autoimmune disorders.
- Publication
Annals of the rheumatic diseases, 2005, Vol 64, Issue 5, p765
- ISSN
0003-4967
- Publication type
Journal Article
- DOI
10.1136/ard.2004.026534